“…Our study had several limitations. First, the follow‐up duration was shorter than previous studies of postoperative abdominal donor‐site complications after pharyngolaryngectomy (means 9 months vs 2‐29 months) . Because mechanical bowel obstruction can develop at any time during a person's life, the risk may have been underestimated.…”
Section: Discussionmentioning
confidence: 96%
“…Previous studies that evaluated abdominal donor‐site complications after pharyngolaryngectomy were all from a single institution, with surgery performed by one to several head and neck surgeons . The incidence proportions in those studies ranged from 2.4%‐13%.…”
Section: Discussionmentioning
confidence: 99%
“…To date, several studies have evaluated donor‐site complications after the harvesting of a free jejunum graft . However, their results were limited because they were based on a single institutional experience and the sample sizes (n = 30‐313) were not large enough to capture the rare occurrence of donor‐site complications.…”
In pharyngolaryngectomy, careful attention should be paid to the risk of abdominal complications and, thus, to the graft choice, especially in elderly patients.
“…Our study had several limitations. First, the follow‐up duration was shorter than previous studies of postoperative abdominal donor‐site complications after pharyngolaryngectomy (means 9 months vs 2‐29 months) . Because mechanical bowel obstruction can develop at any time during a person's life, the risk may have been underestimated.…”
Section: Discussionmentioning
confidence: 96%
“…Previous studies that evaluated abdominal donor‐site complications after pharyngolaryngectomy were all from a single institution, with surgery performed by one to several head and neck surgeons . The incidence proportions in those studies ranged from 2.4%‐13%.…”
Section: Discussionmentioning
confidence: 99%
“…To date, several studies have evaluated donor‐site complications after the harvesting of a free jejunum graft . However, their results were limited because they were based on a single institutional experience and the sample sizes (n = 30‐313) were not large enough to capture the rare occurrence of donor‐site complications.…”
In pharyngolaryngectomy, careful attention should be paid to the risk of abdominal complications and, thus, to the graft choice, especially in elderly patients.
“…Although microvascular reconstruction has greatly improved, there remains much room for improvement and further study. Particularly, the rate of graft failure mainly as a result of graft malperfusion is between 3% and 24% [3,4,15]. A necrotic FJG transferred to the neck is a life-threatening complication because it is adjacent to major vessels, such as the carotid arteries and the jugular veins, that can become infected by necrotic tissue.…”
“…Consistent with our results, previous studies have reported that strictures usually occurred at the distal esophageal anastomosis and, thus, the distal site may be more commonly affected because of its narrower lumen. Additionally, CRT could be an additional risk factor for stricture formation at that location . CRT causes mucosal injury and toxicity, so‐called mucositis, which is the initiating event in a cascade leading to a mucosal fibrotic stricture …”
This retrospective analysis demonstrated the efficacy and safety of exclusive EBD for pharyngo-upper esophageal strictures occurring after treatment for head and neck cancer, indicating that the therapeutic application of EBD could be extended to such strictures. Patients who underwent chemoradiotherapy and surgery experienced more restenosis; hence, such patients should be carefully followed up after EBD treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.